PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 16445636-0 2006 The antiobesity drug Orlistat induces cytotoxic effects, suppresses Her-2/neu (erbB-2) oncogene overexpression, and synergistically interacts with trastuzumab (Herceptin) in chemoresistant ovarian cancer cells. Orlistat 21-29 erb-b2 receptor tyrosine kinase 2 Homo sapiens 68-77 16445636-0 2006 The antiobesity drug Orlistat induces cytotoxic effects, suppresses Her-2/neu (erbB-2) oncogene overexpression, and synergistically interacts with trastuzumab (Herceptin) in chemoresistant ovarian cancer cells. Orlistat 21-29 erb-b2 receptor tyrosine kinase 2 Homo sapiens 79-85 15870086-13 2005 Moreover, hypersensitivity to orlistat-induced cytotoxicity was observed in MCF-7 breast cancer cells engineered to overexpress Her2/neu (MCF-7/Her2-18 cells), which exhibit a significant up-regulation of FAS expression and activity. Orlistat 30-38 erb-b2 receptor tyrosine kinase 2 Homo sapiens 128-136 15870086-13 2005 Moreover, hypersensitivity to orlistat-induced cytotoxicity was observed in MCF-7 breast cancer cells engineered to overexpress Her2/neu (MCF-7/Her2-18 cells), which exhibit a significant up-regulation of FAS expression and activity. Orlistat 30-38 erb-b2 receptor tyrosine kinase 2 Homo sapiens 128-132